N-(3,4-Dichlorophenyl)-2-((5-((4-methoxybenzyl)thio)-1,3,4-thiadiazol-2-yl)thio)acetamide

Catalog No. :
ACVJSN529
CAS No. :
477313-78-3
Molecular Formula :
C18H15Cl2N3O2S3
Molecular Weight :
472.44

IUPAC Name:N-(3,4-dichlorophenyl)-2-((5-((4-methoxybenzyl)thio)-1,3,4-thiadiazol-2-yl)thio)acetamide

N-(3,4-Dichlorophenyl)-2-((5-((4-methoxybenzyl)thio)-1,3,4-thiadiazol-2-yl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3,4-Dichlorophenyl)-2-((5-((4-methoxybenzyl)thio)-1,3,4-thiadiazol-2-yl)thio)acetamide
IUPAC NameN-(3,4-dichlorophenyl)-2-((5-((4-methoxybenzyl)thio)-1,3,4-thiadiazol-2-yl)thio)acetamide
MDL No.MFCD03224139
Molecular FormulaC18H15Cl2N3O2S3
Molecular Weight472.44
SMILESO=C(NC1=CC=C(Cl)C(Cl)=C1)CSC2=NN=C(SCC3=CC=C(OC)C=C3)S2
InChI KeyUAOKVPCKLWGRSJ-UHFFFAOYSA-N
SynonymN-(3,4-DI-CL-PH)-2-((5-((4-MEO-BENZYL)THIO)-1,3,4-THIADIAZOL-2-YL)THIO)ACETAMIDE;N-(3,4-dichlorophenyl)-2-({5-[(4-methoxybenzyl)sulfanyl]-1,3,4-thiadiazol-2-yl}sulfanyl)acetamide;SALOR-INT L227552-1EA;Acetamide, N-(3,4-dichlorophenyl)-2-[[5-[[(4-methoxyphenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]thio]-
CAS No.477313-78-3

Synthetic Route by SureRoute

1. ACVJSN529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDBIH579 route compound structure diagram
    ACDBIH57920149-84-2 In Stock
  4. Then
  5. ACVJSN529 route product structure diagram
    ACVJSN529477313-78-3
Inquiry

2. ACVJSN529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVJSN529 route product structure diagram
    ACVJSN529477313-78-3
Inquiry

Comments (0)